
Data on the comparative merits of drugs recommended to manage heart failure (HF) are limited. A recent case-control study compared HF patients who died within 24 months of diagnosis with those who survived to 24 months after a HF diagnosis. The researchers compared the 2 groups to see which therapies…
Read more »
India’s first successful implant of HeartMate 3™ LVAD with Full MagLev™
Patients no longer need to travel abroad for HeartMate 3™, the world’s first commercially approved fully magnetically-levitated left ventricular assist device (LVAD), proven to show high survival rates in advanced heart failure patients…
Read more »